Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting in Children with Cancer

被引:11
作者
Cefalo, M. G. [1 ]
Ruggiero, A. [1 ]
Maurizi, P. [1 ]
Attina, G. [1 ]
Arlotta, A. [1 ]
Riccardi, R. [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Div Pediat Oncol, I-00168 Rome, Italy
关键词
Nausea; vomiting; chemotherapy; children; antiemetic agents; MODERATELY EMETOGENIC CHEMOTHERAPY; CISPLATIN-INDUCED EMESIS; ANTIEMETIC THERAPY; DOUBLE-BLIND; NEUROKININ-1; ANTAGONIST; PEDIATRIC ONCOLOGY; PHASE-III; APREPITANT; PREVENTION; ONDANSETRON;
D O I
10.1179/joc.2009.21.6.605
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nausea and vomiting are respectively the first and third most relevant chemotherapy-associated side effects in pediatric oncology, despite the introduction of new antiemetic agents. Symptoms change according to the antineoplastic agents used, and are influenced by age since emotional and psychological aspects play an important role. Studies conducted on new antiemetic therapies usually focus on adult populations affected by tumors, whereas there are very few series including pediatric patients, who are even more severely affected by this specific side effect.
引用
收藏
页码:605 / 610
页数:6
相关论文
共 50 条
  • [41] Patient-Centered Management of Chemotherapy-Induced Nausea and Vomiting
    Grunberg, Steven
    CANCER CONTROL, 2012, 19 (02) : 10 - 15
  • [42] Evaluation of outpatient cancer patients' use of nonpharmacological methods in the management of chemotherapy-induced nausea and vomiting
    Ergin, Eda
    Midilli, Tulay Sagkal
    Akdag, Eda
    Kirgoz, Ceyda
    CUKUROVA MEDICAL JOURNAL, 2021, 46 (02): : 574 - 582
  • [43] New options and controversies in the management of chemotherapy-induced nausea and vomiting
    Koth, Sara M.
    Kolesar, Jill
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (11) : 812 - 819
  • [44] Chemotherapy-Induced Nausea and Vomiting
    Rapoport, Bernardo Leon
    Molasiotis, Alexander
    Raftopoulos, Haralambos
    Roila, Fausto
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [45] Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity
    Vig, Sierra
    Seibert, Laurel
    Green, Myke R.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (01) : 77 - 82
  • [46] Chemotherapy-Induced Nausea and Vomiting Mitigation With Music Interventions
    Kiernan, Jason M.
    Stark, Jody Conradi
    Vallerand, April H.
    ONCOLOGY NURSING FORUM, 2018, 45 (01) : 88 - 95
  • [47] Poor chemotherapy-induced nausea and vomiting control in children receiving intermediate or high dose methotrexate
    Vol, Helen
    Flank, Jacqueline
    Lavoratore, Sara R.
    Nathan, Paul C.
    Taylor, Tracey
    Zelunka, Elyse
    Maloney, Anne Marie
    Dupuis, L. Lee
    SUPPORTIVE CARE IN CANCER, 2016, 24 (03) : 1365 - 1371
  • [48] Chemotherapy-induced nausea and vomiting: a pediatric approach.
    Morales, Daniel Ortiz
    Marquez, Itzel Lizbeth Flores
    Gallardo, Iris Yael Gallardo
    ACTA PEDIATRICA DE MEXICO, 2023, 44 (05): : 399 - 407
  • [49] Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting
    Mortimer, Toni Leigh
    Mabin, Tom
    Engelbrecht, Anna-Mart
    FUTURE ONCOLOGY, 2019, 15 (09) : 1035 - 1050
  • [50] Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron
    Lorusso, Vito
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 917 - 925